Literature DB >> 21276311

Performance of culture and drug susceptibility testing in pulmonary tuberculosis patients in northern China.

W Qi1, A D Harries, S G Hinderaker.   

Abstract

Multidrug-resistant tuberculosis (MDR-TB) is a growing problem in China. In 2008, all smear-positive pulmonary TB patients in a city in northern China were expected to undergo routine culture and drug susceptibility testing (DST). We assessed the performance of this system. There were 915 patients, of whom 356 (39%) had culture performed; 275 (30%) had positive cultures and 236 (26%) had DST. Of the 236 patients with DST, 6% of new and 32% of previously treated patients had MDR-TB. Culture and DST is an important service for the correct management of patients, and solutions to improve the current system need to be considered.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21276311

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN： 1027-3719            Impact factor:   2.373


  20 in total

1.  Screening retreatment tuberculosis patients for drug resistance in mid-west Nepal: how well are we doing?

Authors:  M B Tharu; A D Harries; S Goel; S Srivastava; A M V Kumar; M Adhikari; B Shrestha; B Maharjan; H Khadka
Journal:  Public Health Action       Date:  2014-03-21

2.  Characteristics and outcomes of tuberculosis patients who fail to smear convert at two months in Sri Lanka.

Authors:  W Jayakody; A D Harries; S Malhotra; S de Alwis; S Samaraweera; N Pallewatta
Journal:  Public Health Action       Date:  2013-03-21

3.  Operational research training: the course and beyond.

Authors:  K Bissell; A D Harries; A J Reid; M Edginton; S G Hinderaker; S Satyanarayana; D A Enarson; R Zachariah
Journal:  Public Health Action       Date:  2012-09-21

4.  Diagnosis and treatment of TB patients with rifampicin resistance detected using Xpert(®) MTB/RIF in Zimbabwe.

Authors:  K Charambira; S Ade; A D Harries; R T Ncube; C Zishiri; C Sandy; H Mutunzi; K Takarinda; P Owiti; P Mafaune; P Chonzi
Journal:  Public Health Action       Date:  2016-06-21

5.  MDR-TB in Puducherry, India: reduction in attrition and turnaround time in the diagnosis and treatment pathway.

Authors:  H D Shewade; S Govindarajan; P Thekkur; C Palanivel; M Muthaiah; A M V Kumar; V Gupta; B N Sharath; J P Tripathy; K Vivekananda; G Roy
Journal:  Public Health Action       Date:  2016-12-21

6.  Has TB CARE I sputum transport improved access to culture services for retreatment tuberculosis patients in Zimbabwe?

Authors:  C Timire; K C Takarinda; C Sandy; C Zishiri; A M V Kumar; A D Harries
Journal:  Public Health Action       Date:  2018-06-21

7.  Delay and attrition before treatment initiation among MDR-TB patients in five districts of Gujarat, India.

Authors:  H D Shewade; K S Shringarpure; M Parmar; N Patel; S Kuriya; S Shihora; N Ninama; N Gosai; R Khokhariya; C Popat; H Thanki; B Modi; P Dave; R K Baxi; A M V Kumar
Journal:  Public Health Action       Date:  2018-06-21

8.  MDR-TB screening in a setting with molecular diagnostic techniques: who got tested, who didn't and why?

Authors:  H D Shewade; S Govindarajan; B N Sharath; J P Tripathy; P Chinnakali; A M V Kumar; M Muthaiah; K Vivekananda; A K Paulraj; G Roy
Journal:  Public Health Action       Date:  2015-06-21

9.  Management of previously treated tuberculosis patients in Kalutara district, Sri Lanka: how are we faring?

Authors:  S C Abeygunawardena; B N Sharath; R Van den Bergh; B Naik; N Pallewatte; M N N Masaima
Journal:  Public Health Action       Date:  2014-06-21

10.  Overcoming the health system barriers to early diagnosis and management of multidrug-resistant tuberculosis in a rural setting in North India.

Authors:  Mohammad Abu Bashar; Arun Aggarwal; Sudip Bhattacharya
Journal:  BMJ Case Rep       Date:  2020-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.